[{"address1": "500 Unicorn Park Drive", "address2": "Suite 303", "city": "Woburn", "state": "MA", "zip": "01801", "country": "United States", "phone": "781 222 9600", "website": "https://www.replimune.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer. The company's proprietary tumor-directed oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF, which is in Phase I/II clinical trials for a range of solid tumors. The company is also developing RP2, which is in Phase I clinical trials to express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trial to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.", "fullTimeEmployees": 479, "companyOfficers": [{"maxAge": 1, "name": "Mr. Philip  Astley-Sparke F.S.A.", "age": 53, "title": "Executive Chairman", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 960520, "exercisedValue": 0, "unexercisedValue": 435967}, {"maxAge": 1, "name": "Ms. Emily Luisa Hill", "age": 44, "title": "Chief Financial Officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 593047, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Konstantinos  Xynos M.B.A., M.D., Ph.D.", "age": 57, "title": "Chief Medical Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 668686, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sushil  Patel Ph.D.", "age": 53, "title": "CEO & Director", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 665050, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew  Schwendenman", "age": 48, "title": "Chief Accounting Officer & Treasurer", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shawn  Glidden J.D.", "title": "Senior Vice President of General Counsel", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Camilo  Garcia M.A., M.B.A.", "title": "Chief Human Resource Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Sarchi", "age": 55, "title": "Chief Commercial Officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  Bullock", "title": "Chief Manufacturing Officer & Framingham Site Head", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Nina  Aragam", "title": "Senior Vice President of Portfolio Strategy & Program Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 8, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.76, "open": 8.708, "dayLow": 7.808, "dayHigh": 8.74, "regularMarketPreviousClose": 8.76, "regularMarketOpen": 8.708, "regularMarketDayLow": 7.808, "regularMarketDayHigh": 8.74, "payoutRatio": 0.0, "beta": 0.677, "forwardPE": -3.1040893, "volume": 1438013, "regularMarketVolume": 1438013, "averageVolume": 1006722, "averageVolume10days": 1471560, "averageDailyVolume10Day": 1471560, "bid": 8.27, "ask": 8.44, "bidSize": 12, "askSize": 12, "marketCap": 643674816, "fiftyTwoWeekLow": 4.92, "fiftyTwoWeekHigh": 17.0, "fiftyDayAverage": 8.8783, "twoHundredDayAverage": 11.14605, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 236035360, "profitMargins": 0.0, "floatShares": 53121250, "sharesOutstanding": 77086800, "sharesShort": 9174646, "sharesShortPriorMonth": 9574667, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.1191, "heldPercentInsiders": 0.04513, "heldPercentInstitutions": 1.07305, "shortRatio": 9.41, "shortPercentOfFloat": 0.16430001, "impliedSharesOutstanding": 77086800, "bookValue": 5.395, "priceToBook": 1.5477295, "lastFiscalYearEnd": 1743379200, "nextFiscalYearEnd": 1774915200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -247296992, "trailingEps": -3.07, "forwardEps": -2.69, "enterpriseToEbitda": -0.921, "52WeekChange": 0.6119691, "SandP52WeekChange": 0.09362543, "quoteType": "EQUITY", "currentPrice": 8.35, "targetHighPrice": 31.0, "targetLowPrice": 14.0, "targetMeanPrice": 20.875, "targetMedianPrice": 20.0, "recommendationMean": 1.625, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 483804000, "totalCashPerShare": 6.276, "ebitda": -256352000, "totalDebt": 76165000, "quickRatio": 7.818, "currentRatio": 7.952, "debtToEquity": 18.316, "returnOnAssets": -0.31261, "returnOnEquity": -0.62579, "freeCashflow": -112739872, "operatingCashflow": -192250000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "REPL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1748043232, "regularMarketTime": 1748030401, "exchange": "NMS", "shortName": "Replimune Group, Inc.", "longName": "Replimune Group, Inc.", "fiftyDayAverageChange": -0.52829933, "fiftyDayAverageChangePercent": -0.05950456, "twoHundredDayAverageChange": -2.79605, "twoHundredDayAverageChangePercent": -0.25085568, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1006722, "fiftyTwoWeekLowChange": 3.4300003, "fiftyTwoWeekLowChangePercent": 0.6971545, "fiftyTwoWeekRange": "4.92 - 17.0", "fiftyTwoWeekHighChange": -8.65, "fiftyTwoWeekHighChangePercent": -0.5088235, "fiftyTwoWeekChangePercent": 61.19691, "earningsTimestamp": 1747911600, "earningsTimestampStart": 1754483400, "earningsTimestampEnd": 1754915400, "earningsCallTimestampStart": 1747915200, "earningsCallTimestampEnd": 1747915200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.07, "epsForward": -2.69, "epsCurrentYear": -2.86211, "priceEpsCurrentYear": -2.9174283, "regularMarketChangePercent": -4.6803637, "regularMarketPrice": 8.35, "messageBoardId": "finmb_571664452", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1532093400000, "postMarketChangePercent": 1.67664, "postMarketPrice": 8.49, "postMarketChange": 0.139999, "regularMarketChange": -0.40999985, "regularMarketDayRange": "7.808 - 8.74", "marketState": "CLOSED", "displayName": "Replimune", "trailingPegRatio": null, "__fetch_time": "2025-05-24"}]